
IndraLab
Statements
Tofacitinib inhibits ITCH. 4 / 4
|
4
reach
"The dose selection for tofacitinib was according to a former study in which 0.5% tofacitinib inhibited itch behaviour and inflammation in a mouse model of allergic contact dermatitis, higher doses (when given in acetone) led to irritation of mouse skin, thus it was decided to select a concentration of 0.5% [XREF_BIBR]."